996 related articles for article (PubMed ID: 33028808)
1. Emerging role of tumor cell plasticity in modifying therapeutic response.
Qin S; Jiang J; Lu Y; Nice EC; Huang C; Zhang J; He W
Signal Transduct Target Ther; 2020 Oct; 5(1):228. PubMed ID: 33028808
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-mesenchymal transition and drug resistance: role, molecular mechanisms, and therapeutic strategies.
Sui H; Zhu L; Deng W; Li Q
Oncol Res Treat; 2014; 37(10):584-9. PubMed ID: 25342509
[TBL] [Abstract][Full Text] [Related]
3. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
Du B; Shim JS
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance.
Luo M; Brooks M; Wicha MS
Curr Pharm Des; 2015; 21(10):1301-10. PubMed ID: 25506895
[TBL] [Abstract][Full Text] [Related]
5. Cellular Plasticity in Cancer.
Yuan S; Norgard RJ; Stanger BZ
Cancer Discov; 2019 Jul; 9(7):837-851. PubMed ID: 30992279
[TBL] [Abstract][Full Text] [Related]
6. Role of Claudin Proteins in Regulating Cancer Stem Cells and Chemoresistance-Potential Implication in Disease Prognosis and Therapy.
Gowrikumar S; Singh AB; Dhawan P
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861759
[TBL] [Abstract][Full Text] [Related]
7. Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.
BharathwajChetty B; Sajeev A; Vishwa R; Aswani BS; Alqahtani MS; Abbas M; Kunnumakkara AB
Cancer Metastasis Rev; 2024 Mar; 43(1):321-362. PubMed ID: 38517618
[TBL] [Abstract][Full Text] [Related]
8. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.
Shibue T; Weinberg RA
Nat Rev Clin Oncol; 2017 Oct; 14(10):611-629. PubMed ID: 28397828
[TBL] [Abstract][Full Text] [Related]
9. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of epithelial-mesenchymal transition and cancer stem cells.
Topcul M; Cetin I
J BUON; 2016; 21(2):312-9. PubMed ID: 27273939
[TBL] [Abstract][Full Text] [Related]
11. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
Mitra A; Mishra L; Li S
Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
[TBL] [Abstract][Full Text] [Related]
12. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell (CSC) resistance drivers.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
[TBL] [Abstract][Full Text] [Related]
14. The emerging role of the gut microbiome in cancer cell plasticity and therapeutic resistance.
Mondal P; Meeran SM
Cancer Metastasis Rev; 2024 Mar; 43(1):135-154. PubMed ID: 37707749
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-to-mesenchymal-like transition events in melanoma.
Pedri D; Karras P; Landeloos E; Marine JC; Rambow F
FEBS J; 2022 Mar; 289(5):1352-1368. PubMed ID: 33999497
[TBL] [Abstract][Full Text] [Related]
16. Controversies around epithelial-mesenchymal plasticity in cancer metastasis.
Williams ED; Gao D; Redfern A; Thompson EW
Nat Rev Cancer; 2019 Dec; 19(12):716-732. PubMed ID: 31666716
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-to-Mesenchymal Transition: Liaison between Cancer Metastasis and Drug Resistance.
Du F; Liu H; Lu Y; Zhao X; Fan D
Crit Rev Oncog; 2017; 22(3-4):275-282. PubMed ID: 29604904
[TBL] [Abstract][Full Text] [Related]
18. Targeting Cancer Stemness in the Clinic: From Hype to Hope.
Saygin C; Matei D; Majeti R; Reizes O; Lathia JD
Cell Stem Cell; 2019 Jan; 24(1):25-40. PubMed ID: 30595497
[TBL] [Abstract][Full Text] [Related]
19. Clinical Evolution of Epithelial-Mesenchymal Transition in Human Carcinomas.
Navas T; Kinders RJ; Lawrence SM; Ferry-Galow KV; Borgel S; Hollingshead MG; Srivastava AK; Alcoser SY; Makhlouf HR; Chuaqui R; Wilsker DF; Konaté MM; Miller SB; Voth AR; Chen L; Vilimas T; Subramanian J; Rubinstein L; Kummar S; Chen AP; Bottaro DP; Doroshow JH; Parchment RE
Cancer Res; 2020 Jan; 80(2):304-318. PubMed ID: 31732654
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic cancer stem cells: emerging target for designing novel therapy.
Li Y; Kong D; Ahmad A; Bao B; Sarkar FH
Cancer Lett; 2013 Sep; 338(1):94-100. PubMed ID: 22445908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]